Carlos Cordon-Cardo | Icahn School of Medicine
Robust neutralizing antibodies to SARS-CoV-2 infection persist for months
COVID-19: Developing the Mount Sinai Antibody Test - Physician's Channel - Mount Sinai New York
COVID-19 pandemic (2019-21) - PLOS Collections
Carlos Cordon-Cardo, MD, PhD – Mount Sinai | 5th International Prostate Cancer Symposium and World Congress of Urologic Oncology
Events - Englander Institute for Precision Medicine
About Dr. Cordon-Cardo | Carlos Cordon-Cardo, MD, PhD
Carlos Cordón-Cardó | Sociedad | EL PAÍS
Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs (IARC WHO Classification of Tumours): 9789283224150: Medicine & Health Science Books @ Amazon.com
Mount Sinai Health System on Twitter: "Testing early for viral load may lead to better care for #patients with #COVID19. This study was led by Carlos Cordon-Cardo, MD, PhD: https://t.co/4VfUfsaOiJ #MountSinaiNews https://t.co/QMm5GwemUN" /
Events - Englander Institute for Precision Medicine
Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic
Carlos Cordon-Cardo, MD, PhD - Physician's Channel - Mount Sinai New York
Early Warning Score reduces incidence of serious events in general ward - Case study | Philips
Medical Technology Blog
Maturity Models: CIO's Guide to a Successful Enterprise Imaging Strategy - Blog | Philips
Mount Sinai applies algorithms, AI to classify disease | Fierce Healthcare
Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic
Carlos Cordon-Cardo, MD, PhD - Physician's Channel - Mount Sinai New York
Mount Sinai's Blood Test to Detect Antibodies to COVID-19 Receives Emergency Use Authorization From U.S. Food and Drug Administration - BroadcastMed
El oncólogo Carlos Cordón-Cardó | Sociedad | EL PAÍS
Robust neutralizing antibodies to SARS-CoV-2 infection persist for months
Journal of Medical Virology: Early View
The non-compliant patient, reconsidered | Philips
